2. Signaling Pathways
  3. Immunology/Inflammation
  4. ALCAM/CD166
  5. ALCAM/CD166 Inhibitor

ALCAM/CD166 Inhibitor

ALCAM/CD166 Inhibitors (2):

Cat. No. Product Name Effect Purity
  • HY-P99788
    Praluzatamab
    		Inhibitor
    Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.
  • HY-P990330
    Anti-ALCAM/CD166 Antibody (AT002)
    		Inhibitor
    Anti-ALCAM/CD166 Antibody (AT002) is a CHO-expressed human antibody that targets ALCAM/CD166. Anti-ALCAM/CD166 Antibody (AT002) contains a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-ALCAM/CD166 Antibody (AT002) can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).